• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Seasonal Flu Vaccine Less Effective Than Hoped

    Written by Charlotte McLeod
    |
    Jan. 15, 2015 04:18PM PST

    CBC News reported that early estimates show that this season’s flu vaccine reduces risk of flu by just 23 percent among Americans. For Canadians, the vaccine is even less effective.

    CBC News reported that early estimates show that this season’s flu vaccine reduces risk of flu by just 23 percent among Americans. For Canadians, the vaccine is even less effective.

    As quoted in the market news:

    Canadian and U.S. health officials have said the most common type of flu circulating this season is H3N2, which is not well-matched with the seasonal flu vaccine.

    On Thursday, the U.S. Centers for Disease Control and Prevention released an estimate based on 2,321 American children and adults who got the flu vaccine between November and January. The CDC said vaccinated people had a 23 per cent lower chance of winding up at the doctor with the flu.

     Click here to read the full CBC News report.

    The Conversation (0)

    Go Deeper

    AI Powered
    Life Science Outlook: World Edition

    Life Science Outlook: World Edition

    Moderna

    Moderna

    Latest News

    BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer

    Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule

    BPH Energy Limited September 2026 Quarter Operations Report

    Quarterly Activities/Appendix 4C Cash Flow Report

    Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES